Moderna’s cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some products and questioned when the company can return to profitability.
Source link
Moderna’s spending cuts, pipeline shakeup leave doubts about a rebound, analysts say
Date:
Share post: